Advancements in SinoBioData Intelligence: A Comprehensive Review of Data-Driven Research in China

• China has rapidly advanced in biomedical data infrastructure, with major investments in biobanks and sequencing initiatives. • AI and machine learning are increasingly integrated into Chinese biomedical research, enabling breakthroughs in drug discovery and diagnostics. • Data sharing and privacy regulations remain critical challenges, necessitating balanced policies to foster innovation while protecting patient rights. • International collaboration is essential for standardizing data formats and maximizing the global impact of SinoBioData intelligence.